Post-approval studies (Phase 4)Ended earlyNCT05737186
What this trial is testing
SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency
Who this might be right for
Heart Failure With Reduced Ejection FractionRenal Insufficiency, Chronic
Peking University People's Hospital 11